UNITED STATES SECURITIES AND EXCHANGE COMMISSION
|
Washington, DC 20549
|
______________________
|
FORM 8-K
|
CURRENT REPORT PURSUANT
|
TO SECTION 13 OR 15(D) OF THE
|
SECURITIES EXCHANGE ACT OF 1934
|
July 28, 2016
|
Date of Report (Date of earliest event reported)
|
BOVIE MEDICAL CORPORATION
|
(Exact name of registrant as specified in its Charter)
|
Delaware
|
012183
|
11-2644611
|
||
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
4 Manhattanville Road, Suite 106
Purchase, New York 10577
|
(Address of principal executive offices) (Zip Code)
|
(914) 468-4009
|
Registrant's telephone number, including area code
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Name of Directors
|
Votes For
|
Votes Withheld
|
Andrew Makrides
|
12,390,574
|
564,949
|
Robert L. Gershon
|
12,526,897
|
428,646
|
J. Robert Saron
|
12,424,029
|
531,514
|
John C. Andres
|
12,494,740
|
428,748
|
Charles T. Orsatti
|
12,489,092
|
434,396
|
Michael Geraghty
|
12,519,985
|
435,548
|
Lawrence J. Waldman
|
12,493,740
|
429,748
|
Scott Davidson
|
12,497,092
|
426,396
|
Votes For
|
Votes Against
|
Votes Abstained
|
21,968,634
|
504,067
|
28,865
|
Votes For
|
Votes Against
|
Votes Abstained
|
11,600,471
|
1,259,585
|
95,487
|
Date: August 2, 2016
|
BOVIE MEDICAL CORPORATION
|
|
By: /s/ Robert L. Gershon
|
||
Robert L. Gershon
|
||
Chief Executive Officer
|